DaVita Inc. (NYSE: DVA), a leading provider of kidney care services for
those diagnosed with chronic kidney disease (CKD), today released
a study finding patient outcomes in the company’s newly acquired centers
showed dramatic improvements over the two years following their switch
to DaVita® ownership. Reflecting DaVita’s proven track record for
superior clinical care, the study, published in the Clinical Journal of
the American Society of Nephrology, reveals that patients demonstrated
better clinical results in several critical areas of disease management
after their dialysis centers were acquired by DaVita.
“The research showed an initial gap between existing and newly acquired
DaVita clinics, but that gap narrowed or vanished inside of two years”
Comparing newly acquired centers to existing DaVita centers, the study
found a higher baseline of clinical outcomes in existing centers, but
the newly-acquired centers showed dramatic improvements and nearly
caught up by the end of the two-year evaluation period. Key findings of
the study include: